相似文献
1
Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?
Gut. 2007 Apr;56(4):577-83. doi: 10.1136/gut.2005.082925. Epub 2006 Sep 6.
2
Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease.
Gut. 2005 Jun;54(6):789-96. doi: 10.1136/gut.2004.046516.
3
Obesity, visceral fat and Crohn's disease.
Curr Opin Clin Nutr Metab Care. 2010 Sep;13(5):574-80. doi: 10.1097/MCO.0b013e32833cf0f4.
4
Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?
Gut. 2012 Jan;61(1):86-94. doi: 10.1136/gutjnl-2011-300391. Epub 2011 Sep 19.
5
Inflammatory alterations in mesenteric adipose tissue in Crohn's disease.
Gastroenterology. 1999 Jul;117(1):73-81. doi: 10.1016/s0016-5085(99)70552-4.
6
Mesenteric fat in Crohn's disease: the hot spot of inflammation?
Gut. 2012 Jan;61(1):3-5. doi: 10.1136/gutjnl-2011-301354. Epub 2011 Nov 7.
7
Role of Fgf receptor 2c in adipocyte hypertrophy in mesenteric white adipose tissue.
Mol Cell Endocrinol. 2008 Jun 11;287(1-2):13-9. doi: 10.1016/j.mce.2008.02.010. Epub 2008 Feb 19.
8
Disturbance of Fatty Acid Desaturation Mediated by FADS2 in Mesenteric Adipocytes Contributes to Chronic Inflammation of Crohn's Disease.
J Crohns Colitis. 2020 Nov 7;14(11):1581-1599. doi: 10.1093/ecco-jcc/jjaa086.
9
Mesenteric Adipocyte Dysfunction in Crohn's Disease is Associated with Hypoxia.
Inflamm Bowel Dis. 2016 Jan;22(1):114-26. doi: 10.1097/MIB.0000000000000571.
10
Targeting a Hallmark of Crohn's Disease: Browning of the Hypertrophic Mesenteric Adipose Tissue as a Novel Strategy to Reduce Inflammation?
J Crohns Colitis. 2023 Aug 21;17(8):1177-1178. doi: 10.1093/ecco-jcc/jjad059.
引用本文的文献
1
Mesentery morphological features on computed tomography for preoperative prediction of tumor invasion and lymph node metastasis in colon cancer.
World J Clin Oncol. 2025 Jul 24;16(7):108095. doi: 10.5306/wjco.v16.i7.108095.
2
Kynurenic acid derived from mesentery regulates mesenteritis and colitis via inducing white adipose browning in Crohn's disease.
Mol Metab. 2025 Jul 5;99:102203. doi: 10.1016/j.molmet.2025.102203.
3
Mesenteric adipose tissue in Crohn's disease alters the immune response of the ileal mucosa and increases angiogenesis and fibrosis.
Sci Rep. 2025 Jul 2;15(1):22591. doi: 10.1038/s41598-025-07147-7.
4
Clinical outcomes of conventional versus extended mesenteric resection in limited ileo-colonic Crohn's disease: a systematic review and meta-analysis.
Int J Colorectal Dis. 2025 Jun 18;40(1):144. doi: 10.1007/s00384-025-04937-3.
5
To cut or not to cut? Extended mesenteric excision during intestinal resection does not impact the postoperative recurrence nor the postoperative complications in Crohn's disease: a systematic review and meta-analysis.
Tech Coloproctol. 2025 Mar 8;29(1):79. doi: 10.1007/s10151-025-03110-w.
6
Interplay between creeping fat and gut microbiota: A brand-new perspective on fecal microbiota transplantation in Crohn's disease.
World J Gastroenterol. 2025 Jan 14;31(2):100024. doi: 10.3748/wjg.v31.i2.100024.
7
The mesenteric adipokine SFRP5 alleviated intestinal epithelial apoptosis improving barrier dysfunction in Crohn's disease.
iScience. 2024 Dec 1;27(12):111517. doi: 10.1016/j.isci.2024.111517. eCollection 2024 Dec 20.
8
The Impact of Obesity on the Prevalence and Complications of Perianal Fistulas of Crohn's Disease.
Dig Dis Sci. 2025 Jan;70(1):323-332. doi: 10.1007/s10620-024-08729-7. Epub 2024 Nov 16.
9
Assessment of body composition-related imaging parameters indicative of sarcopenia in Chinese patients with Crohn's disease: correlation with disease severity and biologic efficacy.
Am J Transl Res. 2024 Oct 15;16(10):5427-5440. doi: 10.62347/ZPZR8134. eCollection 2024.
10
Comprehensive assessment of distinct abdominal fat compartments beyond liver content in overweight/obese patients using MRI and ultrasound imaging.
Abdom Radiol (NY). 2025 Mar;50(3):1457-1466. doi: 10.1007/s00261-024-04591-3. Epub 2024 Sep 21.
本文引用的文献
1
Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein.
Gut. 2006 Nov;55(11):1561-7. doi: 10.1136/gut.2005.084301. Epub 2006 Apr 28.
2
Adipocyte-derived hormones, cytokines, and mediators.
Endocrine. 2006 Feb;29(1):81-90. doi: 10.1385/endo:29:1:81.
3
Evidence for a role of developmental genes in the origin of obesity and body fat distribution.
Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6676-81. doi: 10.1073/pnas.0601752103. Epub 2006 Apr 14.
4
Induction of leptin resistance through direct interaction of C-reactive protein with leptin.
Nat Med. 2006 Apr;12(4):425-32. doi: 10.1038/nm1372. Epub 2006 Apr 2.
5
Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease.
Atherosclerosis. 2006 Oct;188(2):231-44. doi: 10.1016/j.atherosclerosis.2006.02.010. Epub 2006 Apr 3.
6
Role of resistin in inflammation and inflammation-related diseases.
Cell Mol Immunol. 2006 Feb;3(1):29-34.
7
Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells.
Regul Pept. 2006 May 15;134(2-3):105-13. doi: 10.1016/j.regpep.2006.02.001. Epub 2006 Mar 10.
8
The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases.
Nat Clin Pract Gastroenterol Hepatol. 2005 Dec;2(12):580-6. doi: 10.1038/ncpgasthep0359.
9
Adipose tissue: a regulator of inflammation.
Best Pract Res Clin Endocrinol Metab. 2005 Dec;19(4):547-66. doi: 10.1016/j.beem.2005.07.009.
10
Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come.
Best Pract Res Clin Endocrinol Metab. 2005 Dec;19(4):525-46. doi: 10.1016/j.beem.2005.07.008.
Zotero 插件